Exicure, Inc.
Support and Resistance Levels
Past performance
News About XCUR
All events for XCUR
All deals for XCUR
Financial Ratios
Financial Statements
XCUR vs Sector & Peers
About Exicure, Inc.
Exicure, Inc. is a biotechnology firm that utilizes its unique spherical nucleic acid (SNA) platform to create therapies for neurological conditions and hair loss. Its primary experimental candidate, SCN9A, is currently undergoing preclinical evaluation for addressing neuropathic and chronic pain. The company has entered into a strategic partnership with AbbVie Inc. to advance SNA-based solutions for various hair loss conditions, under a collaboration, option, and license agreement. Additionally, a separate collaborative effort with Ipsen S.A. aims to investigate, develop, and commercialize novel spherical nucleic acids targeting Huntington's disease and Angelman syndrome. Established in 2011, Exicure's corporate base is located in Chicago, Illinois. Website exicuretx.com
Headquarters Redwood City, CA, US